Elan's $1 billion drug royalty deal aids bid defense
By Padraic Halpin DUBLIN (Reuters) - Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe conce...
Read More »By Padraic Halpin DUBLIN (Reuters) - Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe conce...
Read More »By Dorene Internicola NEW YORK (Reuters) - Baby boomers, the generation that vowed to stay forever young, are getting older, designi...
Read More »
By Genevra Pittman NEW YORK (Reuters Health) - Men who were exposed to Agent Orange chemicals used during the Vietnam War are at hig...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Teenagers who text while driving are also more likely to engage in other risky activi...
Read More »By Angus McDowall HOFUF, Saudi Arabia (Reuters) - On the third day after his father's death from a respiratory infection, Hussein al...
Read More »
By Angus McDowall RIYADH (Reuters) - World Health Organization (WHO) officials said on Sunday it seemed likely a new coronavirus tha...
Read More »
By David Morgan WASHINGTON (Reuters) - Health and Human Services Secretary Kathleen Sebelius is asking companies for financial donat...
Read More »
PARIS (Reuters) - A second diagnosis of the new SARS-like coronavirus has been confirmed in France, the Health Ministry said on Sund...
Read More »(Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of nam...
Read More »By Toni Clarke (Reuters) - Some simple safety techniques for food handling and preparation could help delicatessens and other food s...
Read More »